Andra AP-fonden’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-32,700
| Closed | -$5.79M | – | 691 |
|
|
2020
Q1 | $5.79M | Buy |
32,700
+900
| +3% | +$169K | 0.21% | 102 |
|
|
2019
Q4 | $6.08M | Hold |
31,800
| – | – | 0.17% | 240 |
|
|
2019
Q3 | $5.35M | Sell |
31,800
-4,800
| -13% | -$782K | 0.16% | 316 |
|
|
2019
Q2 | $6.13M | Sell |
36,600
-2,400
| -6% | -$332K | 0.18% | 235 |
|
|
2019
Q1 | $5.71M | Buy |
+39,000
| New | +$5.65M | 0.17% | 286 |
|
|
2018
Q3 | $9.11M | Buy |
47,800
+3,700
| +8% | +$680K | 0.23% | 97 |
|
|
2018
Q2 | $7.35M | Sell |
44,100
-400
| -0.9% | -$64.2K | 0.2% | 175 |
|
|
2018
Q1 | $7.49M | Buy |
44,500
+18,600
| +72% | +$3.12M | 0.19% | 172 |
|
|
2017
Q4 | $4.24M | Buy |
25,900
+5,300
| +26% | +$951K | 0.1% | 323 |
|
|
2017
Q3 | $4.22M | Buy |
20,600
+3,600
| +21% | +$837K | 0.1% | 318 |
|
|
2017
Q2 | $4.13M | Hold |
17,000
| – | – | 0.1% | 303 |
|
|
2017
Q1 | $4.06K | Sell |
17,000
-2,700
| -14% | -$629K | 0.1% | 313 |
|
|
2016
Q4 | $4.14M | Buy |
19,700
+8,100
| +70% | +$1.68M | 0.11% | 286 |
|
|
2016
Q3 | $2.67M | Sell |
11,600
-800
| -6% | -$195K | 0.07% | 422 |
|
|
2016
Q2 | $2.87M | Sell |
12,400
-800
| -6% | -$184K | 0.07% | 424 |
|
|
2016
Q1 | $3.54M | Sell |
13,200
-2,300
| -15% | -$658K | 0.09% | 329 |
|
|
2015
Q4 | $4.84M | Sell |
15,500
-100
| -0.6% | -$29.8K | 0.14% | 195 |
|
|
2015
Q3 | $4.24M | Buy |
+15,600
| New | +$4.79M | 0.12% | 239 |
|
|
2015
Q2 | – | Sell |
-23,195
| Closed | -$6.9M | – | 632 |
|
|
2015
Q1 | $6.9M | Buy |
23,195
+7,895
| +52% | +$2.25M | 0.2% | 146 |
|
|
2014
Q4 | $3.94M | Sell |
15,300
-14,270
| -48% | -$3.57M | 0.09% | 333 |
|
|
2014
Q3 | $7.13M | Buy |
29,570
+9,670
| +49% | +$2.16M | 0.17% | 197 |
|
|
2014
Q2 | $4.44M | Sell |
19,900
-24,400
| -55% | -$5.05M | 0.1% | 317 |
|
|
2014
Q1 | $9.12M | Buy |
44,300
+38,400
| +651% | +$7.61M | 0.21% | 145 |
|
|
2013
Q4 | $991K | Buy |
5,900
+2,300
| +64% | +$360K | 0.02% | 498 |
|
|
2013
Q3 | $518K | Buy |
3,600
+200
| +6% | +$26.6K | 0.01% | 534 |
|
|
2013
Q2 | $429K | Buy |
+3,400
| New | +$385K | 0.01% | 541 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Andra AP-fonden's AGN Position: Q2 2020 in Review
Andra AP-fonden sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 32,700 shares — an estimated $5.79M sold.
Andra AP-fonden first reported a position in AGN in Q2 2013 and held it in 26 quarters. The position peaked at $9.12M in Q1 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Andra AP-fonden reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Andra AP-fonden sold 32,700 Allergan plc shares in Q2 2020, an estimated $5.79M.
- Andra AP-fonden first reported a position in Allergan plc in Q2 2013 and held it in 26 quarters.
- Andra AP-fonden's Allergan plc position peaked at $9.12M in Q1 2014.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Andra AP-fonden's 13F filing for Q2 2020, filed 6 Aug 2020.